|
 Novembre 2021 - La compétitivité de la France au sein de l’Europe
Responsible innovation in neurotechnology, practical examples from translational projects
By Tracy LAABS
PhD, Chief Development Officer, Wyss Center for Bio and Neuroengineering
Progress in neurotechnology is advancing rapidly driven by unmet needs for therapies to treat neurological disorders. New technologies raise ethical questions and responsible innovation is needed at every step of the development process.
Here we describe two research projects breaking new ground in neurotechnology and neurobiology respectively. The first, a brain-computer interface, enables people who are completely locked-in to communicate in real time using their brain signals to control a communication device. The second assesses the feasibility of using photobiomodulation (PBM) as a therapy in the fight against neurodegenerative disorders like Parkinson’s and Alzheimer’s disease.
We briefly consider the ethical aspects of both projects and conclude that organizations developing new neurotechnologies should consult with experts in neuroethics and put quality systems which require development in line with accepted international standards in place early in the development process. They should additionally engage in an open dialogue with society around the impact of their technology. Finally, they should anticipate potential unintended use of new technologies and engage with professional organizations to facilitate the translation of applied research ethics into government policy.
 Télécharger gratuitement l'article
Retour au sommaire
 November 2021 - French competitiveness within Europe
Responsible innovation in neurotechnology, practical examples from translational projects
Tracy Laabs,
PhD, Chief Development Officer, Wyss Center for Bio and Neuroengineering
Progress in neurotechnology is advancing rapidly driven by unmet needs for therapies to treat neurological disorders.
New technologies raise ethical questions and responsible innovation is needed at every step of the development process.
Here we describe two research projects breaking new ground in neurotechnology and neurobiology respectively. The first, a brain-computer interface, enables people who are completely locked-in to communicate in real time using their brain signals to control a communication device. The second assesses the feasibility of using photobiomodulation (PBM) as a therapy in the fight against neurodegenerative disorders like Parkinson’s and Alzheimer’s disease.
We briefly consider the ethical aspects of both projects and conclude that organizations developing new neurotechnologies should consult with experts in neuroethics and put quality systems which require development in line with accepted international standards in place early in the development process. They should additionally engage in an open dialogue with society around the impact of their technology. Finally, they should anticipate potential unintended use of new technologies and engage with professional organizations to facilitate the translation of applied research ethics into government policy.
Retour au sommaire
|
